The CMT2A mouse model may present additional CNS symptoms, offering insights for comprehensive pathogenic investigations and potentially expanding our understanding of the disease beyond its classical peripheral neuropathy presentation. This evidence concerns the gene MFN2 and peripheral neuropathy.